Risk factors and treatment efficiency for lung cancer patients with venous thromboembolism
10.3969/j.issn.1006-5725.2014.06.018
- VernacularTitle:肺癌化疗患者合并静脉血栓栓塞症的危险因素及治疗分析
- Author:
Quanfang CHEN
;
Wei WANG
;
Xiaoying ZOU
;
Zhian LING
;
Yanbin WU
;
Jinliang KONG
;
Banghao XU
;
Qinghua DU
- Publication Type:Journal Article
- Keywords:
Lung cancer;
Venous thromboembolism;
Risk factors;
Treatment
- From:
The Journal of Practical Medicine
2014;(6):891-894
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the risk factors and treatment efficiency for lung cancer patients with venous thromboembolism (VTE). Methods Total 282 cases of lung cancer patients with VTE were enrolled into two groups , including the VTE group and the non-VTE group , for comparation analysis based on a series of clinical data. Results The occupation rate of adenocarcinoma and Ⅳ period were 65.28% and 87.50% in VTE group, respectively, higher than those of 51.43% and 75.71% in the non-VTE group. The increased rate of blood viscosity and d-dimer respectively were 65.28% and 70.83%, higher than those of 51.43% and 56.67% in the non-VTE group, with significant differences (P < 0.05, respectively). Result of logistic regression analysis showed that tumor stage , d-dimer levels , smoking , age , and blood viscosity levels were highly correlated with venous thrombosis in patients with lung cancer, and the OR value among them was 3.802, 2.339, 5.814, 3.875 and 6.404, respectively, with significant differencees (P < 0.05, respectively). Conclusions Lung adenocarcinoma with stage Ⅳ, smoking , age and increase of blood viscosity and d-dimer were the important risk factors for VTE in patients with lung cancer chemotherapy. Timely assessment of risk factors and early anticoagulation therapy in lung cancer patients with venous thromboembolism associated with VTE can improve the treatment efficacy and reduce the complications.
